Search clinical trials for: Trilaciclib; HR-Negative Breast Cancer; Adjuvant Therapy

Total 74089 results

Alliance for Clinical Trials in Oncology
National Cancer Institute (NCI)

Completed

Testosterone in Treating Postmenopausal Patients With Arthralgia Caused by Adjuvant Aromatase Inhibitor Treatment

Breast Cancer | Arthralgia | Hot Flashes | Sexual Dysfunction | Musculoskeletal Complications

United States, Puerto Rico
University of Virginia
Syndax Pharmaceuticals

Completed

A Pilot Study of the Combination of Entinostat With Capecitabine in High Risk Breast Cancer After Neo-adjuvant Therapy (Breast49)

Breast Cancer | Metastatic Breast Cancer

United States
Seoul National University Hospital

Active, not recruiting

Breast Density Change Predicting Response to Adjuvant Aromatase Inhibitor (DEAR)

Invasive Breast Cancer | Estrogen Receptor Positive Breast Cancer

Korea, Republic of
Qamar Khan
Novartis Pharmaceuticals

Active, not recruiting

Letrozole Plus Ribociclib or Placebo as Neo-adjuvant Therapy in ER-positive, HER2-negative Early Breast Cancer (FELINE)

Breast Cancer

United States
Mayo Clinic
National Cancer Institute (NCI)

Completed

Doxorubicin and Cyclophosphamide Followed By Trastuzumab, Paclitaxel, and Lapatinib in Treating Patients With Early-Stage HER2-Positive Breast Cancer That Has Been Removed By Surgery

Breast Cancer | Cardiac Toxicity

United States
Hoffmann-La Roche

Completed

A Study of Trastuzumab Emtansine (Kadcyla) Plus Pertuzumab (Perjeta) Following Anthracyclines in Comparison With Trastuzumab (Herceptin) Plus Pertuzumab and a Taxane Following Anthracyclines as Adjuvant Therapy in Participants With Operable HER2-Positive Primary Breast Cancer

Breast Cancer

United States, France, Czechia, Italy, Korea, Republic of, Australia, Belgium, Brazil, Canada, Germany, Guatemala, Hong Kong, Hungary, Panama, Peru, Poland, Spain, Taiwan, United Kingdom, Colombia, Bosnia and Herzegovina, Chile, El... and more
Radiation Therapy Oncology Group
National Cancer Institute (NCI); NRG Oncology; NCIC Clinical Trials Group; Cancer...

Completed

Radiation Therapy With or Without Optional Tamoxifen in Treating Women With Ductal Carcinoma in Situ

Breast Cancer

United States, Canada
NSABP Foundation Inc
Genentech, Inc.; US Oncology Research

Completed

A Clinical Trial Comparing the Combination of TC Plus Bevacizumab to TC Alone and to TAC for Women With Node-Positive or High-Risk Node-Negative, HER2-Negative Breast Cancer

Breast Cancer

United States, Ireland
Georgetown University
Bristol-Myers Squibb

Active, not recruiting

OXEL: Immune Checkpoint or Capecitabine or Combination Therapy as Adjuvant Therapy for TNBC With Residual Disease

Triple Negative Breast Cancer

United States
University Hospital, Toulouse

Completed

Impact of Adjuvant Hormone Therapy on Bone and Cardiovascular Risk (IMPACTTHKS)

Breast Cancer

France
iOMEDICO AG
Arbeitsgemeinschaft fur Internistische Onkologie; Arbeitskreis Klinische Studien

Completed

Tumour Registry Breast Cancer (TMK)

Breast Cancer
Tao OUYANG

Active, not recruiting

Clinical Study of Adjuvant Therapy on Post-menopausal Women With Breast Cancer Under the Guidance of the Results of Preoperative Endocrinotherapy

Breast Cancer

China
SCRI Development Innovations, LLC
Eli Lilly and Company; Celgene Corporation

Completed

Neo-adjuvant Gemcitabine, Epirubicin, ABI-007 (GEA) in Locally Advanced or Inflammatory Breast Cancer

Breast Cancer

United States
NYU Langone Health
National Cancer Institute (NCI)

Completed

Toll-like Receptor (TLR) 7 Agonist, Cyclophosphamide, and Radiotherapy for Breast Cancer With Skin Metastases

Breast Cancer | Metastatic Breast Cancer | Recurrent Breast Cancer

United States
Pfizer

Completed

Aromasin® Interventional Study Of Early Invasive Breast Cancer Patients In China

Breast Neoplasms

China
NSABP Foundation Inc
Genentech, Inc.; International Drug Development Institute

Completed

Therapy With Bevacizumab (BEV), Epirubicin, and Cyclophosphamide Followed by Docetaxel Plus Trastuzumab and BEV Given as Neoadjuvant or Adjuvant Therapy for Women With Locally Advanced HER2 Positive Invasive Breast Cancer

Breast Cancer

United States, Canada
Novartis Pharmaceuticals

Completed

Adjuvant Ribociclib With Endocrine Therapy in Hormone Receptor+/HER2- High Risk Early Breast Cancer (EarLEE-1)

Breast Cancer

United States
NSABP Foundation Inc
Washington University School of Medicine; Breast Cancer Research Foundation

Active, not recruiting

NSABP Biospecimen Discovery Project

Breast Cancer

United States
Amgen
Daiichi Sankyo, Inc.

Terminated

Study of Denosumab as Adjuvant Treatment for Women With High Risk Early Breast Cancer Receiving Neoadjuvant or Adjuvant Therapy (D-CARE)

Breast Cancer

United States, Denmark, France, Italy, Belgium, Canada, Czechia, Germany, Netherlands, United Kingdom, Korea, Republic of, Peru, Philippines, Poland, Russian Federation, Taiwan, Spain, Australia, Hong Kong, Slovakia, Israel, Hungary, Portug... and more
Robert Bosch Gesellschaft für Medizinische Forschung...

Completed

Genotype and Phenotype Guided Supplementation of TAMoxifen Standard Therapy With ENDOXifen in Breast Cancer Patients (TAMENDOX)

Breast Cancer | DCIS

Germany
Genentech, Inc.

Completed

A Dose Escalation Study Evaluating the Safety and Tolerability of GDC-0032 in Participants With Locally Advanced or Metastatic Solid Tumors or Non-Hodgkin's Lymphoma (NHL) and in Combination With Endocrine Therapy in Locally Advanced or Metastatic Hormone Receptor-Positive Breast Cancer

Non-Hodgkin's Lymphoma | Solid Cancers

United States, Spain, France, Canada
Haukeland University Hospital
Pfizer; AstraZeneca; Helse Vest

Active, not recruiting

PErsonalized TREatment of High-risk MAmmary Cancer - the PETREMAC Trial (PETREMAC)

Breast Cancer

Norway
National Cheng-Kung University Hospital

Active, not recruiting

The Validation of Sentinel Lymph Node Biopsy After Neo-adjuvant Chemotherapy in Breast Cancer Patients

Breast Cancer | Neoadjuvant Therapy | Sentinel Lymph Node Biopsy

Taiwan
Danish Breast Cancer Cooperative Group
Danish Cancer Society

Active, not recruiting

Hypofractionated Loco-regional Adjuvant Radiation Therapy of Breast Cancer Combined With a Simultaneous Integrated Boost

Fibrosis | Lymphedema

Denmark
Southwest Oncology Group
National Cancer Institute (NCI); Eastern Cooperative Oncology Group; NCIC Clinical... and other collaborators

Completed

S0307 Phase III Trial of Bisphosphonates as Adjuvant Therapy for Primary Breast Cancer.

Breast Cancer
Washington University School of Medicine
Merck Sharp & Dohme LLC

Terminated

Epicutaneous Cryoimmunotherapy Combined With Pembrolizumab for Cutaneous Metastatic Breast Cancer

Metastatic Breast Cancer

United States
Puma Biotechnology, Inc.

Completed

Study Evaluating The Effects Of Neratinib After Adjuvant Trastuzumab In Women With Early Stage Breast Cancer (ExteNET)

Breast Cancer

United States, Spain, Korea, Republic of, China, United Kingdom, Canada, France, Australia, Denmark, Switzerland, Japan, Malaysia, Italy, Singapore, Taiwan, Belgium, Croatia, Czechia, Romania, Germany, Bahamas, Brazil, Bulgaria, Colombia and more
Jiangsu HengRui Medicine Co., Ltd.

Enrolling by invitation

Phase III Study ：SHR6390/Placebo Combined With Endocrine Therapy for the Adjuvant Treatment of Hormone Receptor Positive,Human Epidermal Receptor 2 Negative

Hormone Receptor Positive,Human Epidermal Receptor 2 Negative, Node-positive, High Risk, Early Stage，Female Breast Cancer

China
St. Olavs Hospital
Norwegian University of Science and Technology

Completed

Adjuvant Endocrine Therapy in Early Stage Breast Cancer: Adherence and Clinical Outcome

Breast Neoplasm

Norway
Hoffmann-La Roche

Completed

A Safety and Tolerability Study of Assisted and Self-Administered Subcutaneous (SC) Herceptin (Trastuzumab) as Adjuvant Therapy in Early Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast Cancer (SafeHER)

Breast Neoplasms

Hungary, Italy, United Kingdom, Canada, Czechia, Bulgaria, Croatia, Dominican Republic, France, Germany, Greece, Guatemala, Hong Kong, Indonesia, Ireland, Korea, Republic of, Netherlands, Panama, Peru, Poland, Portugal, Slovakia, Spain and more
Clinica Luganese Moncucco
Swiss National Science Foundation; Curzio Rüegg, MD, Head of Department, University... and other collaborators

Completed

Adjuvant Radiotherapy on Circulating Cells in Breast Cancer Patients (CCB-RT)

Breast Cancer

Switzerland
Center of Personalized Medicine, Pirogova
I.M. Sechenov First Moscow State Medical University; Center for New Medical...

Unknown

Personalized Evidence-based Treatment in Patients With Invasive Breast Cancer

Breast Cancer-specific Survival

Russian Federation
ETOP IBCSG Partners Foundation

Terminated

Liposomal Doxorubicin Compared With Observation or Cyclophosphamide and Methotrexate in Treating Older Women Who Have Undergone Surgery for Breast Cancer (CASA)

Breast Cancer

Italy, Australia, Belgium, Switzerland, Slovenia, Hungary, Sweden, New Zealand, Romania
University of British Columbia
University of Ottawa; Canadian Cancer Society (CCS); British Columbia Cancer... and other collaborators

Unknown

Aerobic Exercise and Cognitive Functioning in Women With Breast Cancer (ACTIVATE)

Breast Neoplasms

Canada
NYU Langone Health

Completed

Concurrent Adjuvant Carboplatin and Accelerated Radiotherapy for Triple Negative Breast Cancer

Breast Cancer

United States
Hoffmann-La Roche

Completed

HELENA Study: An Observational Study of Perjeta (Pertuzumab) in First-Line Treatment in Patients With Her2-Positive Advanced Breast Cancer After Adjuvant Herceptin Therapy

Breast Cancer

Germany
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)

Completed

Vaccine Therapy and QS21 in Treating Patients With Metastatic Breast Cancer

Breast Cancer

United States
University of California, Davis

Completed

Impact of Individualized Radiotherapy Plan Review in Patients Receiving Adjuvant Radiotherapy for Breast Cancer

Breast Cancer

United States
National University Hospital, Singapore

Unknown

A Prospective Study on Effect of Systemic Adjuvant Therapy on Cognitive and Brain Function of Breast Cancer Patients

Breast Cancer

Singapore
University of Texas Southwestern Medical Center

Completed

Capecitabine and Radiation Therapy in Treating Patients With Nonmetastatic Breast Cancer After Surgery

Breast Cancer

United States
Case Comprehensive Cancer Center

Completed

Radiation Therapy After Lumpectomy in Treating Women With Ductal Carcinoma in Situ or Invasive Breast Cancer

Breast Cancer

United States
The University of Hong Kong

Unknown

Dual Therapy With Interferon Beta-1b and Clofazimine for COVID-19

COVID-19

China
Eli Lilly and Company

Completed

A Study of LY3295668 Erbumine in Participants With Breast Cancer That Has Spread to Other Parts of the Body

Metastatic Breast Cancer

Belgium, United States
Fudan University
Chinese Anti-Cancer Association

Completed

Minus Anthracycline or Short-Term Versus Epirubicin and Cyclophosphamide Followed by Paclitaxel Regimen for Adjuvant Breast Cancer Therapy

Primary Breast Cancer

China
Celgene

Completed

Bioequivalence & Food Effect Study in Patients With Solid Tumor or Hematologic Malignancies

Melanoma | Sarcoma | Neoplasms | Lymphoma | Renal Cell Carcinoma | Acute Myeloid Leukemia | Myelodysplastic Syndromes | Leukemia | Breast Cancer | Small Cell Lung Cancer | Multiple Myeloma | Hodgkin's Lymphoma | Non-Hodgkin's Lymphoma | Non-Small Cell Lung Cancer | Osteosarcoma | Glioblastoma Multiforme | Metastatic Breast... and other conditions

United States
Fudan University

Completed

A Randomized Trial Comparing EC-wPversus EP-wP as Adjuvant Therapy for Operable Breast Cancer Patients Less Than 40 Years Old

Breast Neoplasms

China
Gynecologic Oncology Group
National Cancer Institute (NCI)

Terminated

Gemcitabine Hydrochloride and Docetaxel Followed by Doxorubicin Hydrochloride or Observation in Treating Patients With High-Risk Uterine Leiomyosarcoma Previously Removed by Surgery

Uterine Corpus Leiomyosarcoma | Stage I Uterine Sarcoma AJCC v7

United States, Belgium, France, Spain, United Kingdom, Netherlands, Norway, Venezuela
Shanghai Jiao Tong University School of Medicine

Completed

Traditional Chinese Medicine as Preventive Method for Osteoporosis Induced by Adjuvant Endocrine Therapy (COAT)

Breast Cancer | Osteoporosis

China
Abramson Cancer Center of the University of Pennsylvania
National Cancer Institute (NCI)

Completed

Partial Breast Radiation Therapy in Treating Women Undergoing Breast Conservation Therapy for Early-Stage Breast Cancer

Breast Cancer | Long-term Effects Secondary to Cancer Therapy in Adults | Skin Reactions Secondary to Radiation Therapy

United States
Abramson Cancer Center of the University of Pennsylvania

Completed

The Effects of Radiation in Reconstructed Breasts

Breast Cancer

United States

Search clinical trials for: Trilaciclib; HR-Negative Breast Cancer; Adjuvant Therapy

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Kyrgyzstan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations